Consistent with findings in rodents, decreased Nrg4 circulating levels were observed in individuals with T2DM, gestational diabetes, metabolic syndrome, and CAD, suggesting a protective role of Nrg4 against the development or progression of these metabolic and cardiovascular conditions [166,167,168]. Here, NRG4 is linked to gestational diabetes.